Effects of erlotinib therapy on [(11)C]erlotinib uptake in EGFR mutated, advanced NSCLC

BACKGROUND: In non-small cell lung cancer (NSCLC) patients off erlotinib therapy, positron emission tomography (PET) using [(11)C]erlotinib distinguished epidermal growth factor receptor (EGFR) mutations from wild-type EGFR. However, tumor uptake of [(11)C]erlotinib during erlotinib therapy is unkno...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:EJNMMI Res
Main Authors: Bahce, Idris, Yaqub, Maqsood, Errami, Hanane, Schuit, Robert C., Schober, Patrick, Thunnissen, Erik, Windhorst, Albert D., Lammertsma, Adriaan A., Smit, Egbert F., Hendrikse, N. Harry
Formato: Artigo
Idioma:Inglês
Publicado em: Springer Berlin Heidelberg 2016
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4746207/
https://ncbi.nlm.nih.gov/pubmed/26857779
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13550-016-0169-8
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados